FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019940572> ?p ?o ?g. }

• W2019940572 endingPage "186" @default.
• W2019940572 startingPage "169" @default.
• W2019940572 abstract "Positive results in the in vitro assay for chromosome aberrations sometimes occur with test chemicals that apparently do not react with DNA, being negative in tests for mutation in bacteria, for DNA strand breaks, and for covalent binding to DNA. These chromosome aberrations typically occur over a narrow concentration range at toxic doses, and with mitotic inhibition. Indirect mechanisms, including oxidative damage, cytotoxicity and inhibition of DNA synthesis induced by chemical exposure, may be involved. Understanding when such mechanisms are operating is important in evaluating potential mutagenic hazards, since the effects may occur only above a certain threshold dose. Here, we used two-parameter flow cytometry to assess DNA synthesis inhibition (uptake of bromodeoxyuridine [BrdUrd]) associated with the induction of aberrations in CHO cells by DNA-reactive and non-reactive chemicals, and to follow cell cycle progression. Aphidicolin (APC), a DNA polymerase inhibitor, induces aberrations without reacting with DNA; 50 μM APC suppressed BrdUrd uptake during a 3-h treatment to < 10% of control levels. Several new drug candidates induced aberrations concomitant with marked reductions in cell counts at 20 h (to 50–60% of controls) and suppression of BrdUrd uptake (<15% of control). Several non-mutagenic chemicals and a metabolic poison, which induce DNA double strand breaks and chromosome aberrations at toxic dose levels, also suppressed DNA synthesis. In contrast, the alkylating agents 4-nitroquinoline-1-oxide, mitomycin C, methylnitrosourea, ethylnitrosourea, methylmethane sulfonate and ethylmethane sulfonate, and a topoisomerase II inhibitor, etoposide, produced many aberrations at concentrations that were less toxic (cell counts ≥73% of controls) and gave little inhibition of DNA synthesis during treatment (BrdUrd uptake ≥85% of controls), although cell cycle delay was seen following the 3-h treatment. Thus, inhibition of DNA synthesis at the time of treatment is supporting evidence for an indirect mechanism of aberrations, when there is no direct DNA reactivity." @default.
• W2019940572 created "2016-06-24" @default.
• W2019940572 creator A5011500193 @default.
• W2019940572 creator A5011843472 @default.
• W2019940572 creator A5025466525 @default.
• W2019940572 creator A5035745217 @default.
• W2019940572 creator A5049860439 @default.
• W2019940572 creator A5087455689 @default.
• W2019940572 date "1998-05-01" @default.
• W2019940572 modified "2023-10-07" @default.
• W2019940572 title "DNA synthesis inhibition as an indirect mechanism of chromosome aberrations: comparison of DNA-reactive and non-DNA-reactive clastogens" @default.
• W2019940572 cites W1967004309 @default.
• W2019940572 cites W1979886598 @default.
• W2019940572 cites W1985293825 @default.
• W2019940572 cites W1987580232 @default.
• W2019940572 cites W2009951996 @default.
• W2019940572 cites W2023474297 @default.
• W2019940572 cites W2035946266 @default.
• W2019940572 cites W2036081244 @default.
• W2019940572 cites W2039858663 @default.
• W2019940572 cites W2049160413 @default.
• W2019940572 cites W2056396451 @default.
• W2019940572 cites W2058967943 @default.
• W2019940572 cites W2059195500 @default.
• W2019940572 cites W2075679029 @default.
• W2019940572 cites W2084513454 @default.
• W2019940572 cites W2108355409 @default.
• W2019940572 cites W2173897158 @default.
• W2019940572 doi "https://doi.org/10.1016/s0027-5107(98)00044-x" @default.
• W2019940572 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9685628" @default.
• W2019940572 hasPublicationYear "1998" @default.
• W2019940572 type Work @default.
• W2019940572 sameAs 2019940572 @default.
• W2019940572 citedByCount "97" @default.
• W2019940572 countsByYear W20199405722012 @default.
• W2019940572 countsByYear W20199405722013 @default.
• W2019940572 countsByYear W20199405722014 @default.
• W2019940572 countsByYear W20199405722015 @default.
• W2019940572 countsByYear W20199405722016 @default.
• W2019940572 countsByYear W20199405722017 @default.
• W2019940572 countsByYear W20199405722018 @default.
• W2019940572 countsByYear W20199405722019 @default.
• W2019940572 countsByYear W20199405722020 @default.
• W2019940572 countsByYear W20199405722021 @default.
• W2019940572 countsByYear W20199405722022 @default.
• W2019940572 countsByYear W20199405722023 @default.
• W2019940572 crossrefType "journal-article" @default.
• W2019940572 hasAuthorship W2019940572A5011500193 @default.
• W2019940572 hasAuthorship W2019940572A5011843472 @default.
• W2019940572 hasAuthorship W2019940572A5025466525 @default.
• W2019940572 hasAuthorship W2019940572A5035745217 @default.
• W2019940572 hasAuthorship W2019940572A5049860439 @default.
• W2019940572 hasAuthorship W2019940572A5087455689 @default.
• W2019940572 hasConcept C104317684 @default.
• W2019940572 hasConcept C134935766 @default.
• W2019940572 hasConcept C143425029 @default.
• W2019940572 hasConcept C153911025 @default.
• W2019940572 hasConcept C185592680 @default.
• W2019940572 hasConcept C2776253266 @default.
• W2019940572 hasConcept C2776639595 @default.
• W2019940572 hasConcept C2776900477 @default.
• W2019940572 hasConcept C30481170 @default.
• W2019940572 hasConcept C552990157 @default.
• W2019940572 hasConcept C55493867 @default.
• W2019940572 hasConcept C64241487 @default.
• W2019940572 hasConcept C73397532 @default.
• W2019940572 hasConcept C86803240 @default.
• W2019940572 hasConceptScore W2019940572C104317684 @default.
• W2019940572 hasConceptScore W2019940572C134935766 @default.
• W2019940572 hasConceptScore W2019940572C143425029 @default.
• W2019940572 hasConceptScore W2019940572C153911025 @default.
• W2019940572 hasConceptScore W2019940572C185592680 @default.
• W2019940572 hasConceptScore W2019940572C2776253266 @default.
• W2019940572 hasConceptScore W2019940572C2776639595 @default.
• W2019940572 hasConceptScore W2019940572C2776900477 @default.
• W2019940572 hasConceptScore W2019940572C30481170 @default.
• W2019940572 hasConceptScore W2019940572C552990157 @default.
• W2019940572 hasConceptScore W2019940572C55493867 @default.
• W2019940572 hasConceptScore W2019940572C64241487 @default.
• W2019940572 hasConceptScore W2019940572C73397532 @default.
• W2019940572 hasConceptScore W2019940572C86803240 @default.
• W2019940572 hasIssue "1-2" @default.
• W2019940572 hasLocation W20199405721 @default.
• W2019940572 hasLocation W20199405722 @default.
• W2019940572 hasOpenAccess W2019940572 @default.
• W2019940572 hasPrimaryLocation W20199405721 @default.
• W2019940572 hasRelatedWork W2002798395 @default.
• W2019940572 hasRelatedWork W2035270946 @default.
• W2019940572 hasRelatedWork W2040670571 @default.
• W2019940572 hasRelatedWork W2093701727 @default.
• W2019940572 hasRelatedWork W2102518494 @default.
• W2019940572 hasRelatedWork W2112663183 @default.
• W2019940572 hasRelatedWork W2123078258 @default.
• W2019940572 hasRelatedWork W4233048651 @default.
• W2019940572 hasRelatedWork W64893300 @default.
• W2019940572 hasRelatedWork W2137706077 @default.
• W2019940572 hasVolume "400" @default.
• W2019940572 isParatext "false" @default.

• next